Overall, our findings contribute to the ever-increasing pool of evidence indicating the significance of lncRNAs in the context of cancer immunity and highlights the urgent need of studies investigating the functional significance of USP30-AS1 in modulating immune responses in ovarian cancer. The gene discussed is USP30; the disease is ovarian carcinoma.